These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3895239)

  • 1. Modulation of murine natural killer cells by Cryptococcus neoformans.
    Bartizal KF; Salkowski CA; Balish E
    Prog Clin Biol Res; 1985; 181():333-6. PubMed ID: 3895239
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of specific antibody to Cryptococcus neoformans by hybridomas in vitro.
    Hall NK; Blackstock R
    Sabouraudia; 1981 Jun; 19(2):157-60. PubMed ID: 7020113
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoresponses and natural killer activity of nude and normal mice under conventional and germfree conditions.
    Suzuki T; Suzuki Y; Maruo N; Yamada T; Katagiri S; Kawamura E; Okano T; Kubota Y; Ghoda A; Yamashita R
    Prog Clin Biol Res; 1985; 181():325-8. PubMed ID: 4022993
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of a gastrointestinal microflora on natural killer cell activity.
    Bartizal KF; Salkowski C; Balish E
    J Reticuloendothel Soc; 1983 May; 33(5):381-90. PubMed ID: 6341580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.
    Wright SC; Bonavida B
    J Immunol; 1981 Apr; 126(4):1516-21. PubMed ID: 7204975
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of natural killer cells in the mouse.
    Burton RC; Bartlett SP; Kumar V; Winn HJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):783-6. PubMed ID: 7268897
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro binding of natural killer cells to Cryptococcus neoformans targets.
    Nabavi N; Murphy JW
    Infect Immun; 1985 Oct; 50(1):50-7. PubMed ID: 3899938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice.
    Hochman PS; Cudkowicz G
    J Immunol; 1979 Sep; 123(3):968-76. PubMed ID: 313958
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver as a tumor cell killing organ: Kupffer cells and natural killers.
    Malter M; Friedrich E; Süss R
    Cancer Res; 1986 Jun; 46(6):3055-60. PubMed ID: 3009008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
    Hidore MR; Murphy JW
    Infect Immun; 1986 Feb; 51(2):547-55. PubMed ID: 3510981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1.
    Jones GJ; Wiseman JC; Marr KJ; Wei S; Djeu JY; Mody CH
    Int Immunol; 2009 Apr; 21(4):423-32. PubMed ID: 19261694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemplating the murine test tube: lessons from natural killer cells and Cryptococcus neoformans.
    Marr KJ; Jones GJ; Mody CH
    FEMS Yeast Res; 2006 Jun; 6(4):543-57. PubMed ID: 16696650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans.
    Murphy JW; McDaniel DO
    J Immunol; 1982 Apr; 128(4):1577-83. PubMed ID: 6120974
    [No Abstract]   [Full Text] [Related]  

  • 17. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.
    Miller MF; Mitchell TG; Storkus WJ; Dawson JR
    Infect Immun; 1990 Mar; 58(3):639-45. PubMed ID: 2407651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine natural killer cell activity by prostaglandins.
    Brunda MJ; Herberman RB; Holden HT
    J Immunol; 1980 Jun; 124(6):2682-7. PubMed ID: 6154736
    [No Abstract]   [Full Text] [Related]  

  • 19. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells.
    Murphy JW
    Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.